Lista de obras - V Knauper - Dominio Público Uruguay

ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells

scientific article published on 29 August 2019

ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cells

artículo científico publicado en 2019

ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors

artículo científico publicado en 2002

An analysis of two refolding routes for a C-terminally truncated human collagenase-3 expressed in Escherichia coli

artículo científico publicado en 2000

Analysis of the contribution of the hinge region of human neutrophil collagenase (HNC, MMP-8) to stability and collagenolytic activity by alanine scanning mutagenesis

scientific article published on 01 March 1997

Biochemical characterization of human collagenase-3

artículo científico publicado en 1996

Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme

artículo científico publicado en 2000

Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).

artículo científico publicado en 2001

Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13.

artículo científico publicado en 2002

Characterization of the AB loop region of TIMP-2. Involvement in pro-MMP-2 activation

scientific article published on 15 June 2006

Characterization of the role of the "MT-loop": an eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases

artículo científico publicado en 2001

Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3.

artículo científico publicado en 2005

Degradation of cartilage aggrecan by collagenase-3 (MMP-13)

scientific article published on 01 February 1996

Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases.

artículo científico publicado en 1995

Differential regulation of TROP2 release by PKC isoforms through vesicles and ADAM17.

artículo científico publicado en 2015

Evaluation of some newer matrix metalloproteinases

artículo científico publicado en 1999

Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution

artículo científico publicado en 1997

Inactivation of human plasma C1-inhibitor by human PMN leucocyte matrix metalloproteinases

scientific article published on 01 September 1991

Inactivation of human plasma alpha 1-proteinase inhibitor by human PMN leucocyte collagenase

artículo científico publicado en 1990

Inhibition of the metalloproteinase domain of mouse TACE

artículo científico publicado en 1999

Isolation and characterization of tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) from human rheumatoid synovial fluid

artículo científico publicado en 1992

Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens

artículo científico publicado en 1997

Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.

artículo científico publicado en 2000

Mercurial activation of human PMN leucocyte type IV procollagenase (gelatinase)

artículo científico publicado en 1992

Methods for studying activation of matrix metalloproteinases.

artículo científico publicado en 2010

Modified platelet deposition on matrix metalloproteinase 13 digested collagen I.

artículo científico publicado en 2015

Neutrophil procollagenase can be activated by stromelysin-2

scientific article published on 01 September 1994

P2X7 receptor activation regulates rapid unconventional export of transglutaminase-2.

artículo científico publicado en 2015

P2X7 receptor-mediated TG2 externalization: a link to inflammatory arthritis?

artículo científico publicado en 2016

Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study

artículo científico publicado en 1999

Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases

artículo científico publicado en 2000

Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).

artículo científico publicado en 2003

Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain

artículo científico publicado en 2001

TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer.

artículo científico publicado en 2017

TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3

artículo científico publicado en 1998

Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme.

artículo científico publicado en 2003

The Adhesion G Protein-Coupled Receptor GPR56/ADGRG1 Is an Inhibitory Receptor on Human NK Cells.

artículo científico publicado en 2016

The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs

artículo científico publicado en 2002

The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3

artículo científico publicado en 2000

The recognition of collagen and triple-helical toolkit peptides by MMP-13: sequence specificity for binding and cleavage

artículo científico publicado en 2014

The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity

scientific article published on 01 March 1993

The role of exon 5 in fibroblast collagenase (MMP-1) substrate specificity and inhibitor selectivity

artículo científico publicado en 2001

The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction

artículo científico publicado en 1997

The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations

artículo científico publicado en 1999

Tissue inhibitor of metalloproteinases-3 peptides inhibit angiogenesis and choroidal neovascularization in mice

artículo científico publicado en 2013

Lista de obras de V Knauper

ADAM15 mediates upregulation of Claudin-1 expression in breast cancer cells

ADAM17-dependent proteolysis of L-selectin promotes early clonal expansion of cytotoxic T cells

ADAMTS1 cleaves aggrecan at multiple sites and is differentially inhibited by metalloproteinase inhibitors

An analysis of two refolding routes for a C-terminally truncated human collagenase-3 expressed in Escherichia coli

Analysis of the contribution of the hinge region of human neutrophil collagenase (HNC, MMP-8) to stability and collagenolytic activity by alanine scanning mutagenesis

Biochemical characterization of human collagenase-3

Biochemical characterization of the catalytic domain of human matrix metalloproteinase 19. Evidence for a role as a potent basement membrane degrading enzyme

Catalytic activities of membrane-type 6 matrix metalloproteinase (MMP25).

Cellular activation of proMMP-13 by MT1-MMP depends on the C-terminal domain of MMP-13.

Characterization of the AB loop region of TIMP-2. Involvement in pro-MMP-2 activation

Characterization of the role of the "MT-loop": an eight-amino acid insertion specific to progelatinase A (MMP2) activating membrane-type matrix metalloproteinases

Cytokine stimulated vascular cell adhesion molecule-1 (VCAM-1) ectodomain release is regulated by TIMP-3.

Degradation of cartilage aggrecan by collagenase-3 (MMP-13)

Different susceptibility of small and large human tenascin-C isoforms to degradation by matrix metalloproteinases.

Differential regulation of TROP2 release by PKC isoforms through vesicles and ADAM17.

Evaluation of some newer matrix metalloproteinases

Identification and characterization of a novel human matrix metalloproteinase with unique structural characteristics, chromosomal location, and tissue distribution

Inactivation of human plasma C1-inhibitor by human PMN leucocyte matrix metalloproteinases

Inactivation of human plasma alpha 1-proteinase inhibitor by human PMN leucocyte collagenase

Inhibition of the metalloproteinase domain of mouse TACE

Isolation and characterization of tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) from human rheumatoid synovial fluid

Limited cleavage of extracellular matrix protein BM-40 by matrix metalloproteinases increases its affinity for collagens

Membrane type 4 matrix metalloproteinase (MMP17) has tumor necrosis factor-alpha convertase activity but does not activate pro-MMP2.

Mercurial activation of human PMN leucocyte type IV procollagenase (gelatinase)

Methods for studying activation of matrix metalloproteinases.

Modified platelet deposition on matrix metalloproteinase 13 digested collagen I.

Neutrophil procollagenase can be activated by stromelysin-2

P2X7 receptor activation regulates rapid unconventional export of transglutaminase-2.

P2X7 receptor-mediated TG2 externalization: a link to inflammatory arthritis?

Phosphinic pseudo-tripeptides as potent inhibitors of matrix metalloproteinases: a structure-activity study

Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases

Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).

Specific collagenolysis by gelatinase A, MMP-2, is determined by the hemopexin domain and not the fibronectin-like domain

TMEFF2 shedding is regulated by oxidative stress and mediated by ADAMs and transmembrane serine proteases implicated in prostate cancer.

TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3

Tailoring tissue inhibitor of metalloproteinases-3 to overcome the weakening effects of the cysteine-rich domains of tumour necrosis factor-alpha converting enzyme.

The Adhesion G Protein-Coupled Receptor GPR56/ADGRG1 Is an Inhibitory Receptor on Human NK Cells.

The enzymatic activity of ADAM8 and ADAM9 is not regulated by TIMPs

The in vitro activity of ADAM-10 is inhibited by TIMP-1 and TIMP-3

The recognition of collagen and triple-helical toolkit peptides by MMP-13: sequence specificity for binding and cleavage

The recombinant catalytic domain of human neutrophil collagenase lacks type I collagen substrate specificity

The role of exon 5 in fibroblast collagenase (MMP-1) substrate specificity and inhibitor selectivity

The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate specificity, and tissue inhibitor of metalloproteinase interaction

The specificity of TIMP-2 for matrix metalloproteinases can be modified by single amino acid mutations

Tissue inhibitor of metalloproteinases-3 peptides inhibit angiogenesis and choroidal neovascularization in mice